Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Series B for Direct Flow Medical brings in $27mm

Executive Summary

Direct Flow Medical (minimally invasive cardiovascular devices) raised $27mm in its Series B financing co-led by first-time backers Johnson & Johnson Development Corp. and Foundation Medical Partners. Other new investors VantagePoint Venture Partners and ePlanet Ventures were joined by returning shareholders EDF Ventures, New Leaf Venture Partners, and Spray Venture Partners. A representative from J&J Development and Foundation Medical will join the company's board. Direct Flow Medical will use the funds to complete clinical feasibility trials of its minimally invasive implant to treat patients with heart valve disease.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies